Canno Biosciences, MB - financials and debts

Company age: 3 y. 11 mo.

Update

Canno Biosciences - Company finances

EUR
2022
From: 2022-10-07
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 2,335 4,283 1,070 1,594
Profit before tax 90 -1,385 759 62
Net profit 90 -1,385 759 529
Equity 2,975 3,318 4,077 4,139
Liabilities 0 200 0 0
Non-current assets 0 0 0 0
Current assets 2,975 3,518 4,077 4,139
Total assets 2,975 3,518 4,077 4,139
Taxes paid
STI taxes - 5 - 114
Financial indicators
Revenue change y/y - +83.4% -75.0% +49.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 3.0% -39.4% 18.6% 12.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 3.0% -41.7% 18.6% 12.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 3.9% -32.3% 70.9% 33.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 3.9% -32.3% 70.9% 3.9%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 0.1 - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Canno Biosciences - Social security debts

The company had no debts to Sodra

Canno Biosciences - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company Canno Biosciences is: 1 €

From To Overdue, €
2026-07-16 2026-09-02 0.58
2026-03-27 2026-07-15 0.45
2026-03-20 2026-03-26 0.9
2025-08-01 2026-03-19 0.45
2025-07-02 2025-07-31 0.42
2025-07-01 2025-07-01 114.42
2025-06-19 2025-06-30 114.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.